Stock 603998 HUNAN FANGSHENG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hunan Fangsheng Pharmaceutical Co., Ltd.

Equities

603998

CNE100001VG6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
11.52 CNY +0.26% Intraday chart for Hunan Fangsheng Pharmaceutical Co., Ltd. +8.88% +5.11%
Apr. 19 Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 10 Fangsheng Pharma's Factories Pass GMP Inspection MT

Business Summary

Hunan FangshengPharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sale of cardiovascular medicine, orthopedic medicine, pediatric medicine, gynecological medicine and anti-infective medicine. The Company's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The Company distributes its products primarily in domestic market.

Number of employees: 1,600

Sales per Business

CNY in Million2022Weight2023Weight Delta
Cardiovascular and Cerebrovascular Disease Medication
23.6 %
449 25.1 % 385 23.6 % -14.34%
Musculoskeletal Systemic Drugs
22.0 %
368 20.5 % 359 22.0 % -2.34%
Other
17.4 %
438 24.4 % 284 17.4 % -35.14%
Medication for Children
11.6 %
151 8.4 % 188 11.6 % +24.74%
Respiratory System Medication
11.0 %
140 7.8 % 180 11.0 % +27.96%
Gynecological Diseases Medication
5.7 %
109 6.1 % 92 5.7 % -15.21%
Anti-infective Drugs
5.0 %
96 5.4 % 82 5.0 % -14.98%
Other Business
3.6 %
41 2.3 % 59 3.6 % +43.19%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,792 100.0 % 1,629 100.0 % -9.12%

Managers

Managers TitleAgeSince
Xiao Li Zhou CEO
 Chief Executive Officer 51 -
Zai Chang Liu DFI
 Director of Finance/CFO 50 21-06-16
Man Xiao
43 -
Meng Gong COO
 Chief Operating Officer 43 -
Bo Chen BRD
 Director/Board Member 45 14-07-30
Bo Ru Zeng IRC
 Investor Relations Contact 30 -
Shi He SEC
 Corporate Secretary 39 21-01-21

Members of the board

Members of the board TitleAgeSince
Xue Min Gao BRD
 Director/Board Member 86 23-09-18
Shou Ying Du BRD
 Director/Board Member 64 20-04-30
Xiong Yuan BRD
 Director/Board Member 59 21-11-15
Bo Chen BRD
 Director/Board Member 45 14-07-30
Xiao Li Zhou CEO
 Chief Executive Officer 51 -
Man Xiao CHM
 Chairman 43 -
Meng Gong COO
 Chief Operating Officer 43 -
Bo Ru Zeng IRC
 Investor Relations Contact 30 -
Yue Xiao BRD
 Director/Board Member 45 22-09-15
Xiang Mu Shen BRD
 Director/Board Member 37 22-11-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 440,761,620 262,446,545 ( 59.54 %) 1,145,000 ( 0.2598 %) 59.54 %

Shareholders

NameEquities%Valuation
Qing Hua Zhang
40.09 %
170,454,375 40.09 % 265 M ¥
GF Fund Management Co., Ltd.
4.408 %
18,740,975 4.408 % 29 M ¥
Huashang Fund Management Co., Ltd.
4.008 %
17,043,200 4.008 % 27 M ¥
Zhong Ou Asset Management Co., Ltd
3.704 %
15,748,331 3.704 % 25 M ¥
Orient Securities Asset Management Co. Ltd.
3.324 %
14,135,340 3.324 % 22 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
2.566 %
10,909,400 2.566 % 17 M ¥
Hotland Innovation Asset Management Co. Ltd.
1.304 %
5,545,900 1.304 % 9 M ¥
Fullgoal Fund Management Co., Ltd.
1.104 %
4,695,254 1.104 % 7 M ¥
CITIC-Prudential Fund Management Co., Ltd.
0.7984 %
3,394,700 0.7984 % 5 M ¥
JPMorgan Asset Management (China) Co Ltd.
0.7602 %
3,232,409 0.7602 % 5 M ¥
NameEquities%Valuation
CITIC-Prudential Fund Management Co., Ltd.
59.60 %
3,394,700 59.60 % 5 M ¥
JPMorgan Asset Management (China) Co Ltd.
56.75 %
3,232,409 56.75 % 5 M ¥
Golden Eagle Asset Management Co., Ltd.
52.83 %
3,008,999 52.83 % 5 M ¥
AXA-SPDB Investment Managers Co., Ltd.
45.12 %
2,569,603 45.12 % 4 M ¥
China Merchants Fund Management Co., Ltd.
28.12 %
1,601,600 28.12 % 2 M ¥
Da Cheng Fund Management Co., Ltd.
27.97 %
1,592,900 27.97 % 2 M ¥
HFT Investment Management Co., Ltd.
21.89 %
1,246,900 21.89 % 2 M ¥
Cinda Fund Management Co. Ltd.
13.08 %
745,200 13.08 % 1 M ¥
Gfund Management Co., Ltd.
12.78 %
727,700 12.78 % 1 M ¥
Guolian Fund Management Co. Ltd.
9.404 %
535,600 9.404 % 833 699 ¥

Company contact information

Hunan Fangsheng Pharmaceutical Co., Ltd.

299 Jiayun Road National High-Tech Indl Dev Zone

410205, Changsha

+

http://www.fangsheng.com.cn
address Hunan Fangsheng Pharmaceutical Co., Ltd.(603998)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Ratings for Hunan Fangsheng Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
11.52 CNY
Average target price
10.31 CNY
Spread / Average Target
-10.50%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
HUNAN FANGSHENG PHARMACEUTICAL CO., LTD. Stock Hunan Fangsheng Pharmaceutical Co., Ltd.
+5.11% 697M
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+18.59% 22.25B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.49% 14.39B
CIPLA LIMITED Stock Cipla Limited
+12.83% 13.55B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.02% 11.27B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.80% 6.95B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.29% 5.01B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-5.36% 4.51B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603998 Stock
  4. Company Hunan Fangsheng Pharmaceutical Co., Ltd.